Idogen AB Valuation
| IDOGEN Stock | SEK 0.12 0.00 0.00% |
Idogen AB seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Idogen AB from evaluating the firm fundamentals such as Return On Equity of -3.21, shares outstanding of 104.37 M, and Return On Asset of -1.33 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Idogen AB's price fluctuation is very steady at this time. Calculation of the real value of Idogen AB is based on 3 months time horizon. Increasing Idogen AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Idogen AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Idogen Stock. However, Idogen AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.12 | Real 0.1 | Hype 0.12 | Naive 0.12 |
The real value of Idogen Stock, also known as its intrinsic value, is the underlying worth of Idogen AB Company, which is reflected in its stock price. It is based on Idogen AB's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Idogen AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Idogen AB helps investors to forecast how Idogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Idogen AB more accurately as focusing exclusively on Idogen AB's fundamentals will not take into account other important factors: Idogen AB Total Value Analysis
Idogen AB is currently estimated to have takeover price of (3.81 M) with market capitalization of 16.12 M, debt of , and cash on hands of . The negative valuation of Idogen AB may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Idogen AB fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(3.81 M) | 16.12 M |
Idogen AB Asset Utilization
One of the ways to look at asset utilization of Idogen is to check how much profit was generated for every dollar of assets it reports. Idogen AB retains a negative application of resources of -1.33 (percent), losing kr0.0133 for each kronor of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each kronor of resources it retains. Simply put, asset utilization of Idogen AB shows how discouraging it operates for each kronor spent on its resources.Idogen AB Ownership Allocation
Idogen AB has a total of 104.37 Million outstanding shares. Idogen AB retains 8.35 (percent) of its outstanding shares held by insiders and 0.42 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Idogen AB Profitability Analysis
Net Loss for the year was (38.85 M) with profit before overhead, payroll, taxes, and interest of 13.91 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Idogen AB's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Idogen AB and how it compares across the competition.
About Idogen AB Valuation
The stock valuation mechanism determines Idogen AB's current worth on a weekly basis. Our valuation model uses a comparative analysis of Idogen AB. We calculate exposure to Idogen AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Idogen AB's related companies.8 Steps to conduct Idogen AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Idogen AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Idogen AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Idogen AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Idogen AB's revenue streams: Identify Idogen AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Idogen AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Idogen AB's growth potential: Evaluate Idogen AB's management, business model, and growth potential.
- Determine Idogen AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Idogen AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Idogen Stock analysis
When running Idogen AB's price analysis, check to measure Idogen AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idogen AB is operating at the current time. Most of Idogen AB's value examination focuses on studying past and present price action to predict the probability of Idogen AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idogen AB's price. Additionally, you may evaluate how the addition of Idogen AB to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |